PepGen Inc. logo

PepGen (PEPG) stock

PEPG · PepGen Inc. · NASDAQ

Website
Market cap
$370.9M
Shares out
94.3M
52-week range41% up the range
$1.31$7.79

What is the latest news on PEPG stock?

PEPG rose 2.88% to $3.94 on Nov 19, 2026. No PEPG story in the last two days; the most recent is below.

13D/Gago
Amendment: SEC Form SCHEDULE 13D/A filed by PepGen Inc.

SCHEDULE 13D/A - PepGen Inc. (0001835597) (Subject)

All PEPG news
Price$3.94-0.03 (-0.76%)
02:30 PM08:45 PM

When does PepGen report earnings?

PepGen last reported on Mar 23, 2023, the date it announced on Mar 16, 2023.

PEPG earnings history

Who owns the most PEPG stock?

Ra Capital Management, L.p. was the largest reported holder of PEPG at the end of Q2 2026, with 20,064,545 shares worth $36.1 million. Next came Commodore Capital LP ($8.1 million) and Viking Global Investors LP ($6.3 million). In all, 72 institutions reported $93.7 million of PEPG in their 13F filings.

All PEPG fund holders

Are insiders buying or selling PEPG?

Insiders are buying. In the last 90 days 1 insider bought $43.1 million of PEPG in trades reported on Form 4. The latest: Ra Capital Management, L.P. bought $43.1 million, reported on Nov 17, 2026.

PEPG insider trades

Financial highlights

Full financials
Net income, TTM
-$73.31M
Free cash flow, TTM
-$63.28M
Cash
$21.96M

For the twelve months ended Sep 30, 2026, from SEC filings. Not investment advice.

Latest news

25 items

PEPG rankings

News · 26 weeks28+100%
2026-05-24: 12026-05-31: 02026-06-07: 02026-06-14: 12026-06-21: 92026-06-28: 02026-07-05: 12026-07-12: 02026-07-19: 02026-07-26: 02026-08-02: 42026-08-09: 02026-08-16: 02026-08-23: 02026-08-30: 02026-09-06: 02026-09-13: 02026-09-20: 02026-09-27: 02026-10-04: 02026-10-11: 02026-10-18: 02026-10-25: 02026-11-01: 02026-11-08: 102026-11-15: 2
2026-05-242026-11-15
Mix1290d
  • SEC Filings5(42%)
  • Earnings2(17%)
  • Offering2(17%)
  • Analyst1(8%)
  • Insider1(8%)
  • 13D/G1(8%)
Activity · 52 weeks6424 active days
Tap a day to see what happenedEarningsInsiderAnalystFilings and news

PepGen Inc. (PEPG) is a Biotechnology: Pharmaceutical Preparations company listed on NASDAQ. In the last 30 days Quantisnow tracked 12 wire items for PEPG, including 5 SEC filings, 2 earnings updates and 2 offerings. The most recent was published Nov 17, 2026.

PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company's lead product candidate is PGN-EDO51, an EDO peptide in Phase I clinical trials to treat individuals with Duchenne muscular dystrophy (DMD). It is also developing PGN-EDODM1, an EDO peptide-conjugated PMO for the treatment of myotonic dystrophy type 1, as well as EDO therapeutic candidates, such as PGN-EDO53, PGN-EDO45, and PGN-EDO44 for the treatment of DMD. The company was founded in 2018 and is headquartered in Cambridge, Massachusetts.

PEPG FAQ

9 questions
  • What does PepGen Inc. do?
    PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company's lead product candidate is PGN-EDO51, an EDO peptide in Phase I clinical trials to treat individuals with Duchenne muscular dystrophy (DMD). It is also developing PGN-EDODM1, an EDO peptide-conjugated PMO for the treatment of myotonic dystrophy type 1, as well as EDO therapeutic candidates, such as PGN-EDO53, PGN-EDO45, and PGN-EDO44 for the treatment of DMD. The company was founded in 2018 and is...
  • Is PEPG profitable?
    No. PepGen Inc. reported a net loss of $73.31M for the twelve months ended Sep 30, 2026.
  • How much cash and debt does PEPG have?
    PepGen Inc. reported $21.96M in cash and cash equivalents on its most recent balance sheet in SEC filings.
  • Where does PEPG stock trade?
    PepGen Inc. (PEPG) is listed on NASDAQ.
  • What sector and industry is PEPG in?
    PepGen Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.
  • When did PepGen Inc. go public?
    PepGen Inc. (PEPG) completed its IPO in 2022.
  • What are analysts saying about PEPG?
    Across the last 6 analyst actions on PepGen Inc., there was 1 upgrade and 2 downgrades. The most recent action was from BofA Securities: Neutral with a $6.00 price target on 2026-11-10.
  • What companies are similar to PEPG?
    Notable peers in the same industry include DYN (Dyne Therapeutics Inc.), WVE (Wave Life Sciences Inc.), TRDA (Entrada Therapeutics Inc.), SRPT (Sarepta Therapeutics Inc.), EWTX (Edgewise Therapeutics Inc.). Compare PEPG side-by-side with any of them on Quantisnow.
  • How can I track PEPG on Quantisnow?
    Quantisnow aggregates PepGen Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow PEPG to receive live email and push alerts on every new disclosure.

Is something on this page wrong, or out of date? Request a change